Could a gut lining 'Reset' help tame diabetes?
NCT ID NCT04725890
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new device, DyaMX, that uses an endoscope to regenerate the lining of the upper small intestine in people with type 2 diabetes. The goal was to see if the procedure is safe and can help improve blood sugar control. 65 adults with diabetes took part. The main focus was on safety, and researchers also tracked changes in blood sugar and weight.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
St Vincent's Hospital Melbourne
Fitzroy, Victoria, VIC 3065, Australia
-
The BMI Clinic
Sydney, New South Wales, 2028, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Daily pill could offer new hope for weight loss in east asian adults
- Blood test could predict who faces rapid kidney decline in diabetes
- Blood test may predict kidney decline in diabetes — a large trial investigates
- Hormone clue may unmask kidney danger in diabetes
- Can a single pill tackle both fatty liver and diabetes?
- Does when you eat carbs and protein reshape blood sugar control?